Efficacy and safety of piroxicam-β-cyclodextrin (PBCD, Brexidol®) - Comparison studies with ibuprofen, naproxen sodium and placebo in the relief of moderate or severe abdominal pain associated with primary dysmenorrhea

Today's Therapeutic Trends

Volumn 17, Issue 4, 1999, Pages 273-288

  Dawood, M Y ^a   Ginsberg, D ^a   Montgomery, M ^a   Smucker, J ^a   Sturley, J W ^a   Littlejohn III, T ^a   Miller, D ^a   Pasquale, S ^a   Warburton, K ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM BETA CYCLODEXTRIN; PLACEBO;

ABDOMINAL PAIN; ADULT; ANALGESIC ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG SOLUBILITY; DYSMENORRHEA; DYSPEPSIA; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL;

EID: 0033428854     PISSN: 07412320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)